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Methods: Fifty-eight cognitively normal (NC) and 71 mild cognitive impairment (MCI) subjects
completed a comprehensive cognitive battery for up to 5 years of follow-up. Composite indices of
cognitive function were derived using a classic theoretical approach and exploratory factor analysis
(EFA). Cognitive variables comprising each factor were averaged to form the EFA composite indices.
Logistic regression was used to investigate whether these cognitive composites can reliably predict
cognitive outcomes.
Results: Neither method predicted decline in NC. The theoretical memory, executive, attention, and
language composites and the EFA-derived “attention/executive” and “verbal memory” composites
were significant predictors of decline in MCI. The best models achieved an area under the curve
of 0.94 in MCI.
Conclusions: The theoretical and the statistically derived cognitive composite approaches are useful
in predicting decline in MCI but not in NC.
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Mild cognitive impairment (MCI) is a risk state for
dementia [1]. Patients with MCI invariably manifest more
cognitive difficulties than one might expect given their age
but can still live independently [1], thus failing to meet theuthorship.
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he Authors. Published by Elsevier Inc. on behalf of the Alzhe
commons.org/licenses/by-nc-nd/4.0/).diagnostic criteria for dementia [2,3]. Although an
estimated 15% of people living with MCI progress to
dementia each year [4], some remain stable or even revert
to exhibit normal cognition [5]. Early identification of cogni-
tively normal (NC) individuals who will convert to MCI and
MCI individuals who will convert to dementia with confi-
dence and high sensitivity will provide the opportunity to
intervene at early stages and have greater potential for modi-
fying the disease course.
Neuropsychological (NP) testing is an essential tool for
assessing cognitive function in both the prodromal andimer’s Association. This is an open access article under the CC BY-NC-ND
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NP testing can capture areas of cognitive decline
relatively early in the disease course [9–11]. NP testing
can effectively capture areas of cognitive decline before
the observation of any clinical symptoms [12]. NP evalua-
tions obtained in the prodromal stages predicted Alz-
heimer’s disease (AD) pathology with 89% accuracy, as
later confirmed by autopsy [13].
Comprehensive NP batteries are often comprised of
different measures that tap into various cognitive domains.
The common practice is to derive composite scores (i.e.,
domains) with a normalized distribution that can be more
easily compared with one another [14]. Traditionally, the
tests that comprise these domains have been chosen on a
theoretical basis. Individual test results are grouped and
interpreted in theoretically derived cognitive domains,
such as attention, language, memory, visuospatial, and ex-
ecutive functions. For example, measures that require
recall are often included in the memory domain and mea-
sures that require concentration are often included in the
attention domain.
Theoretically derived cognitive domains can be used to
predict future cognitive decline [14–17]. The memory
domain has been observed to discriminate best between
NC and MCI, and to be most predictive of progression to
AD [8,12,18,19]. Free recall, recognition memory, and
paired-associate learning have been shown to be impaired
in patients with AD and MCI [8,12,20]. One study showed
that memory assessment predicted diagnosis of normal
cognition and dementia with 94.5% and 66.7% accuracy,
respectively, in a large cohort of older adults [21]. Welsh
et al. [22] demonstrated that the amount of information re-
called after a 10-minute delay on the Consortium to Estab-
lish a Registry for AD [23] differentiated MCI from
healthy normal controls with.90% accuracy. These studies
demonstrate that NP assessments that track deficits in the
memory domain help detect symptom markers essential
for early diagnosis.
Executive functions in everyday life, such as planning a
vacation or creating a grocery list, are often affected early
in the disease course. Such decline is reflected in executive
deficits in NP testing [24,25]. Performance in the
executive domain is highly predictive of future conversion
from MCI to AD [14,15,26]. The executive domain
includes tests that require planning and organization. The
decision whether to include measures into the theoretical
executive domain as opposed to the attention domain is
driven by the additional need to formulate a plan of goal-
directed action or to inhibit an overlearned response.
Notably, some executive tests require problem-solving skills
rather than just processing speed and concentration [24,27].
TheWisconsin Card Sorting Test [28], a novel problem solv-
ing measure, and the Stroop tests [29], a measurement of
response inhibition, are therefore typically categorized as
executive functioning tasks and aid in the prediction of
future cognitive decline [30].NP test groupings can also be derived using statistical
methods [6,7,14,31–35]. Such methods have been shown
to have high accuracy, specificity, and sensitivity in
diagnosing dementia [6,31,33]. By combining individual
test scores into composite scores using multivariate
techniques, diagnoses are less prone to errors caused by
chance and the minimum number of tests needed to detect
cognitive decline decreases [14]. Exploratory factor analysis
(EFA) is a widely used technique that is commonly used to
identify the internal relationships among variables and to
create interpretable composite scores from large sets of vari-
ables. When compared with the theoretical model, where
each of the constituent parts are analyzed separately, com-
posite scores in EFA may be more powerful, in that they
may increase measurement precision, help avoid specific
characteristics of a particular test that may be influenced
by chance, and limit the number of statistical tests needed
to derive a conclusion [14]. This method groups specific tests
within a domain when these tests are highly intercorrelated
(i.e., have high covariance), ensuring that they tap the
same cognitive constructs. The decision of how to group
tests is thus based on the data rather than on theory [36].
When NP tests are run through EFA and the resulting factor
models are produced, incorrectly classified models that
demonstrate a negative error variance can also be revised
and compared with better models [33]. This is important in
analyzing and confirming the best model comprising the
most accurate factors. Previous studies of EFAwith NP tests
have yielded different groupings of tests than the theoretical
model [6,33,37]. Yet, EFA has been shown to accurately
predict cognitive decline in older adults and to improve
diagnostic classification and predict cognitive decline
[6,31,33,37].
Two large studies, one using data from the National Alz-
heimer’s Coordinating Center (N5 12,020) [6] and the other
using data from the Alzheimer’s Disease Neuroimaging
Initiative (N5 819) [7], used EFA to developmodels for pre-
dicting cognitive changes over time and differences within
diagnostic groups. Hayden et al. [6] derived a four-factor so-
lution including memory, executive function, language, and
attention composites, whereas Park et al. [7] also included
a fifth visuospatial factor. Another EFA study of 1288
middle-aged adults with and without family risk factors for
AD derived a different five-factor model comprising verbal
ability, visuospatial, speed and executive function, working
memory, and verbal and memory factors that was able to
explain 63% of the cognitive variance. These factors were
invariant across groups defined by age, gender, family history
of AD, andAPOE ε4 carrier status [33]. Taken together, these
data-driven analytic studies suggest that cognition is simi-
larly organized across the geriatric cognitive spectrum and
that factor scores resulting from these cognitive domains
can be used stably across all groups. The aforementioned
studies also suggest that EFA can effectively differentiate
unique aspects of samples that are relevant, given that
different factors emerged across different cohorts. These
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are when using EFA if only the theoretical method had been
used. For example, although executive functioning tasks are
generally “problem solving” tasks, they also feature tasks
that exhibit aspects of attention, verbal reasoning, visuospa-
tial skills, and more [27]. Many tasks, such as Stroop C [29],
Trailmaking B [38], and Rey Osterrieth Complex
Figure Copy [39], are often grouped into the executive
domain, but can also be categorized in different theoretical
domains [24,40,41]. This can sometimes lead to inaccuracy
in comparing scores stably across all groups because it is
difficult to validate the grouping if a test can be
theoretically assigned to two different domains [41].
Applying principal component analysis (PCA), a
similar variable reduction technique, to a data set of 43
MCI subjects with longitudinal follow-up, Chapman
et al. [31] reduced 49 NP measures into six-component
scores. Five of these components—comprising various
memory test subcomponents (episodic memory, recogni-
tion memory, visuospatial memory, and visuospatial
episodic memory) and two executive measures (speeded
executive functioning and processing speed)—achieved
86% sensitivity and 83% specificity for predicting conver-
sion from MCI to dementia, despite the study’s small
sample size [31].
There are various ways to conduct an EFA depending
on the goals of the researcher and underlying assumptions
of your data set, but there are few absolute guidelines [42].
Although the most common statistical data reduction tech-
nique used in the scientific community is PCA with vari-
max rotation, it has been argued that this technique is
not optimal given the intricacies in “real-world” social sci-
ences data and the fact that PCA is only a data reduction
technique, which is computed without regard to the struc-
ture of the underlying latent variables and therefore can
produce inflated values of variance accounted for by the
components [42]. Although EFA may be the preferred
method of data reduction, there are many decisions, based
on the assumptions one makes about the data, which must
be made along the way that can influence the resulting fac-
tors. First, a factor extraction method must be selected such
as maximum likelihood or principal axis factoring, depend-
ing on the distribution of the data. Then it must be decided
how many factors to retain before rotation. This is most
commonly done using the Kaiser criterion (i.e., retaining
all factors with eigenvalues .1.0) and the scree test, which
can often produce conflicting results. Then the results must
be rotated to simplify and create interpretable results from
the factors. The researcher must decide whether to use an
orthogonal rotation, which generates independent, uncorre-
lated factors or an oblique rotation, which allows for cor-
relation among factors. Once the factor analysis has been
conducted, the researcher may then use the factor loadings
to produce factor scores or, in certain cases where identifi-
cation of the basic subdimensions of the data is the
primary concern, the researcher may opt to use the factorloadings to guide the creation of the composites and
choose an alternative method to compute the scores (e.g.,
by averaging the variables, which load onto each factor).
Each method has its advantages and disadvantages and de-
pending on how different the resulting factors are from
each method, the simplest and most interpretable method
may be preferred. In this study, we explore the use of three
different methods of EFA to create composite scores from
our battery of NP tests and compare them based on their
ability to predict cognitive decline from NC to MCI and
MCI to dementia.
So far the literature suggests that both the theoretical
and experimental variable reduction techniques are useful
and predictive of clinical diagnosis. However, which of
these two approaches is more powerful in predicting
cognitive outcomes should be determined in the same
sample. The goal of our study was to compare the ability
of theoretical and EFA-based groupings of NP tests for
predicting cognitive decline among NC and MCI subjects
in an effort to improve early diagnosis and to determine
whether the statistical multivariate technique more effi-
ciently and effectively predicts cognitive decline
compared with the theoretical model. As factor analysis
helps eliminate tests and factors that do not necessarily
improve the accuracy of diagnosis, we hypothesized that
EFA will achieve better classification accuracy in predict-
ing cognitive decline than the theoretically derived cogni-
tive domain approach.2. Methods
2.1. Study sample
The Imaging and Genetic Biomarkers for AD study
(ImaGene) is a prospective longitudinal study that collects
annual comprehensive clinical and NP data for up to
5 years from NC and MCI subjects. A total of 160 subjects
were initially enrolled from two sources: (1) the ongoing
longitudinal study from University of California, Los An-
geles (UCLA) Alzheimer’s Disease Research Center
(ADRC) and (2) referring neurologists from within and
outside UCLA. Initial inclusion criteria required that par-
ticipants were aged 50 years or older with a Mini-Mental
State Examination (MMSE) score 24 without other
neurological or major psychiatric diseases and no recent
history of drug or alcohol abuse. All eligible subjects
were able to live independently and were free of visual
or hearing impairments that could interfere with cognitive
testing. Research subjects with significant white matter
changes, large vessel strokes, or strategically placed
lacunes that may result in cognitive decline were excluded
from participation. Informed consent was obtained accord-
ing to the restrictions and policies of the UCLA institu-
tional review board.
Initial and longitudinal diagnoses were determined by
consensus decision by a group of neurologists and
Table 1
Demographic characteristics for ImaGene normal controls and UCLA
ADRC normal controls
Variable
ImaGene normal
controls
UCLA ADRC
normal controls P value
Sample size 58 62
Age (y) 69 (8) 69 (6) NS
Education (y) 18 (2) 17 (2) NS
Sex (M/F)
Male 32 (55%) 31 (50%) NS
Female 26 (45%) 31 (50%)
MMSE 29 (1) 29 (1) NS
GDS 1.43 (1.96) 1.37 (2.21) NS
Abbreviations: ADRC, Alzheimer’s Disease Research Center; GDS,
Geriatric Depression Scale; MMSE, Mini-Mental State Examination; NS,
not significant; UCLA, University of California, Los Angeles.
NOTE. Continuous variables are represented as the mean (standard
deviation).
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logical and Communicative Disorders and Stroke and the
Alzheimer’s Disease and Related Disorders criteria for
AD [9] and Petersen criteria for MCI [16]. Diagnosis of
MCI required a score of 1.5 standard deviations less than
the age- and/or education-adjusted norms on at least one
NP test and intact functional abilities corroborated by the
informant. Diagnosis of NC required a score .1.5 standard
deviations compared with age- and/or education-adjusted
norms. The presence of depression was assessed using
the Geriatric Depression Scale (GDS) [43].
For the purposes of our study, subjects were categorized
into four groups: NC subjects who remained stable (NCsta-
ble), NC subjects who progressed to MCI (NCdecliner),
MCI subjects who remained stable (MCIstable), and MCI
subjects who progressed to dementia (MCIdecliner). Of
the 160 enrolled subjects, 12 discontinued and one passed
away before the first follow-up. An additional 18 reverted
back from MCI to NC during follow-up and were excluded
from our analyses. Our final sample consisted of 129
subjects (58 NC and 71 MCI). Length of follow-up varied
(Table 1) because of unforeseen circumstances, such as
health, geographic location, and other factors that led to
the loss of follow-up. Two MCI subjects developed par-
kinsonism, hallucinations, and rapid eye movement
behavior disorder in follow-up. These subjects were diag-
nosed with dementia with Lewy bodies based on the
dementia with Lewy bodies Consortium criteria [44].
One of these subjects passed away and his autopsy results
were consistent with hippocampal sclerosis and early
stages of AD pathology. These two subjects were included
in the MCIdecliner group. The rest of the subjects in the
MCIdecliner group were diagnosed with AD dementia.
2.1.1. Normative sample
A sample of 62 NC subjects enrolled in the longitudinal
study at the UCLAADRCwhowere not part of the ImaGene
study sample described previously and who received thesame NP test battery served as a normative sample. Their
cognitive data were used to estimate the relative contribution
of age for each individual test for age-adjustment of the Im-
aGene cognitive data.
2.2. NP assessment
Subjects were tested annually with an NP battery consist-
ing of MMSE [45], Wechsler Test of Adult Reading [46],
WechslerAdult Intelligence Scale, third edition [47] subtests,
Wechsler Memory Scale—third edition [48] subtests, Trail-
making A and B [38], Stroop Color-Word Interference Test
[29], Boston Naming Test [49], Controlled Oral Word Asso-
ciation Test [50], Rey Osterrieth Complex Figure Copy and
3-minute recall [39], California Verbal Learning Test—sec-
ond edition [51], and Wisconsin Card Sorting Test [28].
2.3. Statistical methods
The goal of this analysis was to predict cognitive decline
fromNCorMCI using composite scores derived from the bat-
tery of cognitive tests administered at baseline. Each cognitive
test score was standardized for age to an independent sample
of NC subjects (N5 62) from the UCLAADRC longitudinal
research cohort (Table 1) using linear regression. For each
cognitive test, linear regression was conducted with age as
the predictor in both the ADRC cohort and the normative.
The standardized score was then calculated by subtracting
the predicted score in the ADRC cohort (as estimated by the
linear regression) from the original score and dividing by the
standard deviation of the residuals from that model. Then
the regressionmodel from the normative controls was applied
to the score resulting in the age-standardized score. Then, all
NPmeasureswere converted to standard z-scores before being
combined into composites. For most cognitive tests, a higher
score indicates better performance, however, for some of the
timed tests (i.e., StroopColor-Word Interference, Trailmaking
A and B), a higher score indicates poorer performance; there-
fore, scores for these tests were multiplied by21. Standardi-
zation was performed before entering the data into both
theoretically and EFA-derived composite indices.
2.4. Data reduction techniques
Two theoretical and three statistical methods were used in
the creation of the composite indices. The former consisted of
(1) averaging the standardized scores for all tests in each of
five theoretically driven domains and (2) using the minimum
standardized score of all the tests included in that theoretical
domain for each subject. For the latter, we compared three
methods using EFA – varimax rotation (average), varimax
rotation (factor scores), and oblique rotation (factor scores).
For all methods, we used factor analysis with squared multi-
ple correlations on the diagonal for the correlation matrix.
The number of factors retained was determined using the
Kaiser criterion (eigenvalue .1) and examination of the
scree plot. Interpretability of the factors was also considered,
Table 2
Demographic characteristics at baseline visit
Variable
NCstable,
N 5 48
NCdecliner,
N 5 10 P value
MCIstable,
N 5 41
MCIdecliner,
N 5 30 P value
Age (y) 69 (8) 72 (10) NS 69 (9) 74 (8) .01
Education (y) 17 (2) 19 (2) .03 15 (3) 16 (3) NS
Sex (M/F)
Male 25 (52%) 7 (70%) NS 17 (41%) 12 (40%) NS
Female 23 (48%) 3 (30%) 24 (59%) 18 (60%)
Race
White 45 (94%) 9 (90%) NS 40 (98%) 28 (93%) NS
African-American 1 (2%) 1 (10%) 0 (0%) 1 (3%)
Asian 1 (2%) 0 (0%) 1 (2%) 0 (0%)
Unknown 1 (2%) 0 (0%) 0 (0%) 1 (3%)
Length of follow-up (y) 4.4 (1.3) 3.9 (1.8) NS 3.0 (1.2) 3.2 (1.2) NS
MMSE 29 (1.1) 28 (1.9) .04 28 (1.6) 26 (3.1) .0002
GDS 0.8 (1.1) 2.1 (2.4) .009 1.7 (1.6) 2.3 (2.3) NS
Antidementia medications 0 (0%) 1 (10%) NS 5 (12%) 8 (27%) NS
Started AD medications during follow-up period 3 (6%) 1 (10%) NS 5 (12%) 24 (80%) ,.0001
Abbreviations: AD, Alzheimer’s disease; GDS, Geriatric Depression Scale; MCI, mild cognitive impairment; MCIdecliner, MCI subjects who progressed to
dementia; MCIstable, MCI subjects who remained stable; MMSE,Mini-Mental State Examination; NC, cognitively normal; NCdecliner, NC subjects who pro-
gressed to MCI; NCstable, NC subjects who remained stable; NS, not significant.
NOTE. Continuous variables are represented as the mean (standard deviations).
Bold text indicates significance.
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icant loadings (.0.30) were retained. For the first EFA-based
method, the factors were rotated using the varimax procedure
to produce independent and uncorrelated factors and cogni-
tive tests were retained on the factor on which they loaded
highest. Cognitive variables comprising each factor were
averaged to form the first set of EFA-derived composites.
In the case where a variable had similar high loadings on
more than one factor, we selected the factor, which made
the most sense theoretically. The second set of EFA-
derived composites was calculated using the factor scores
from this procedure. For the third EFA-based method, the
factors were rotated using the promax procedure, which al-
lows the resulting factors to be correlated.
Logistic regression models were used to predict decliner
status for each of the two subject groupings: NCstable versus
NCdecliner and MCIstable versus MCIdecliner. For each
subject group, a series of models were constructed, including
a single cognitive factor. Each model was adjusted for age,
sex, education, and length of follow-up. C-statistics were
used to determine the classification accuracy of each model.
Leave-one-out cross validation was conducted on the MCI
cohort and the two receiver operating characteristics curves
(ROCs) were compared. Demographics were compared be-
tween the cohorts using the Student t test for continuous vari-
ables and the chi-square test (and Fisher’s exact test where
appropriate) for categorical variables. SAS version 9.4 was
used for all statistical analyses. P value,.05 was considered
statistically significant.3. Results
Table 1 shows the demographic characteristics for the
ImaGene normal controls and UCLA ADRC normal con-trols. No significant differences in age, education, sex,
MMSE, GDS, or antidementia medications at baseline
were seen between the two groups. Among those that were
MCI at baseline, 12% of subjects that remained stable and
80% of subjects who declined over time started antidementia
medications during the study (P ,.0001; Table 2).
Table 2 shows the subject demographics at baseline for
each of the diagnostic progression groups. There were no
significant differences in sex, race, or length of follow-up
in years between the groups. Ten of the 58 NC subjects
(17%) progressed toMCI (mean follow-up: 3.96 1.8 years).
Thirty of the 71 MCI subjects (42%) progressed to dementia
(mean follow-up: 3.2 6 1.2 years). MCI subjects who re-
mained stable were younger than those who declined (MCI-
stable vs. MCIdecliner 69 6 9 vs. 74 6 8 years; P 5 .01).
There was no significant age difference between NC who
declined and those who remained stable. MMSE was signif-
icantly higher in the NC and MCI that remained stable than
those who declined (NCstable vs. NCdecliner: 29 6 1.1 vs.
286 1.9, P5 .04; MCIstable vs. MCIdecliner: 286 1.6 vs.
26 6 3.1, P 5 .0002). Compared with NCstable, NCdeclin-
ers were more highly educated (NCstable vs. NCdecliner:
17 6 2 vs. 19 6 2, P 5 .03). There were no differences in
GDS score in the MCIstable and MCIdecliner groups. The
NCdecliner group had a significantly higher GDS score
compared with the NCstable group (P 5 .009).
The raw and age-standardized cognitive test scores at
baseline for each of the theoretically derived domains
per group are presented in Table 3. The factor loadings
for the varimax-rotated EFA are shown in Table 4. Factors
1 to 3 had eigenvalues .1 and accounted for 84% of the
cumulative variance. The scree plot showing the eigen-
values for each factor is shown in Fig. 1. Factors 1 to 3
had eigenvalues .1.0. The scree plot appears to level
Table 3
Cognitive group means (standard deviations) for each test at baseline
Domains Variables
Raw scores Age-normalized scores
NCstable NCdecliner MCIstable MCIdecliner NCstable NCdecliner MCIstable MCIdecliner
Attention Digit symbol 68 (14) 68 (19) 54 (12) 44 (11) 66 (11) 67 (16) 56 (10) 48 (9)
Digit span forward 11 (2) 10 (2) 10 (2) 9 (2) 10 (2) 10 (2) 9 (3) 9 (2)
Digit span backward 8 (2) 8 (2) 6 (2) 5 (1) 8 (2) 8 (1) 6 (2) 6 (1)
Trails A time 25 (9) 24 (8) 35 (15) 46 (18) 26 (6) 28 (6) 34 (10) 41 (13)
Stroop Color Naming 61 (10) 70 (16) 69 (18) 90 (18) 59 (7) 67 (12) 63 (12) 77 (12)
Stroop Word Reading 46 (8) 49 (10) 51 (10) 58 (9) 45 (9) 49 (11) 49 (13) 57 (9)
Language Boston Naming Test 58 (2) 57 (4) 51 (10) 47 (11) 59 (6) 59 (7) 50 (13) 50 (14)
Animal fluency 51 (15) 49 (11) 34 (12) 30 (15) 52 (10) 48 (6) 40 (9) 38 (9)
FAS fluency 22 (5) 22 (5) 18 (5) 14 (4) 24 (4) 23 (5) 21 (4) 18 (4)
Visuospatial ROCF copy 33 (3) 33 (2) 29 (4) 29 (5) 34 (2) 35 (2) 32 (3) 32 (3)
Block design 13 (3) 13 (3) 10 (3) 10 (3) NA NA NA NA
Memory Logical memory I 45 (9) 39 (8) 31 (11) 15 (8) 50 (5) 48 (3) 43 (7) 35 (6)
Logical memory II 29 (7) 24 (7) 17 (9) 5 (5) 33 (4) 31 (3) 26 (6) 20 (4)
Visual reproduction I 86 (11) 78 (12) 68 (17) 52 (16) 89 (9) 84 (10) 78 (12) 68 (11)
Visual reproduction II 67 (23) 55 (24) 34 (20) 10 (12) 72 (18) 52 (20) 44 (16) 29 (12)
Trails 1–5 total score 51 (12) 47 (12) 36 (10) 25 (7) 56 (8) 51 (8) 45 (7) 39 (7)
Short delay free recall 11 (3) 9 (3) 6 (4) 2 (2) 12 (2) 11 (2) 9 (2) 7 (2)
Long delay free recall 12 (3) 10 (4) 5 (4) 2 (2) 13 (2) 12 (2) 10 (2) 8 (2)
ROCF 3-min delay 21 (6) 18 (6) 12 (7) 7 (6) 22 (4) 21 (5) 15 (4) 13 (5)
Executive Wisconsin Card Sorting Test categories 5 (1) 4 (1) 3 (2) 2 (1) 5 (1) 4 (1) 3 (2) 3 (1)
Trails B time 62 (23) 74 (36) 117 (61) 173 (83) 54 (10) 65 (19) 77 (25) 100 (37)
Stroop interference 110 (21) 139 (44) 140 (36) 189 (65) 104 (15) 118 (28) 121 (21) 140 (42)
Abbreviations: FAS, F-A-S Test for Verbal Fluency; MCI, mild cognitive impairment; MCIdecliner, MCI subjects who progressed to dementia; MCIstable,
MCI subjects who remained stable; NC, cognitively normal; NCdecliner, NC subjects who progressed to MCI; NCstable, NC subjects who remained stable;
ROCF, Rey Osterrieth Complex Figure.
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onto factors 4 to 6 and, therefore, these factors were
excluded from further analyses. The factor loadings forTable 4
Factor loadings for the 6-factor EFA solution—varimax rotation
Cognitive variables Factor 1 Factor 2
Stroop Color Naming 0.82 20.37
Trails A time 0.76 20.27
Trails B time 0.73 20.29
Digit symbol 20.73 0.30
Stroop Word Reading 0.70 20.24
Stroop interference 0.64 20.19
Verbal fluency—FAS 20.51 0.39
Verbal fluency—animal 20.46 0.43
WCST categories 20.46* 0.46*
Short delay free recall 20.35 0.88
Long delay free recall 20.30 0.88
Trails 1–5 total score 20.37 0.79
Logical memory I 20.29 0.61
Logical memory II 20.38 0.61
ROCF copy 20.06 0.14
Visual reproduction II 20.37 0.55
Block design 20.16 0.09
ROCF 3-min delay 20.38 0.48
Visual reproduction I 20.50* 0.41
Boston Naming Test 0.00 0.08
Digit span backward 20.28 0.20
Digit span forward 20.16 0.02
Variance explained by each factor 66% 10%
Abbreviations: EFA, exploratory factor analysis; ROCF, Rey Osterrieth Compl
*Visual Reproduction 1 andWCST categories showed high loadings on two facto
executive measures in factor 1 and visual reproduction 1 with the rest of the visuthe promax-rotated EFA are shown in Table 5. The scree
plot for the EFA with oblique rotation (also shown in
Fig. 1) is very similar to the plot for the orthogonalFactor 3 Factor 4 Factor 5 Factor 6
20.03 0.11 20.11 20.09
20.24 20.11 0.08 20.07
20.26 20.17 20.13 0.01
0.26 0.17 0.16 20.10
20.13 0.26 20.22 20.20
20.05 20.27 20.11 20.14
0.15 0.13 0.28 0.20
0.17 0.12 0.09 20.01
0.36 20.23 0.10 0.02
0.18 20.01 0.10 20.03
0.20 0.14 0.10 0.00
0.18 0.09 0.08 0.05
0.19 0.52 0.12 0.10
0.20 0.49 0.14 0.09
0.64 0.14 0.20 20.17
0.61 20.02 20.01 0.12
0.60 0.23 0.01 0.13
0.60 0.10 0.08 0.06
0.48* 20.15 0.02 0.14
0.17 0.76 0.05 0.20
0.21 0.10 0.78 0.27
20.02 0.35 0.26 0.73
8% 6% 4% 0.5%
ex Figure; WCST, Wisconsin Card Sorting Test.
rs. In all further analysesWCST categories were grouped with the rest of the
ospatial measures in factor 3.
Fig. 1. Scree plot showing the eigenvalues for each factor of the orthogonal rotation (left) and oblique rotation (right).
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factors were retained for further analysis.
The results from the logistic regression analyses are pre-
sented in Table 6. Using the average of the theoretically
derived domains, we found no significant predictors of
decline in the NC group. Within the MCI group, all do-
mains except for the visuospatial were significant predic-
tors of decline to dementia: memory (P 5 .002, area
under the curve [AUC] 5 0.94), executive (P 5 .03,
AUC 5 0.75), attention (P 5 .002, AUC 5 0.82), and lan-
guage (P 5 .03, AUC 5 0.76). Using the test with the min-
imum standardized score as the predictor, we found no
significant predictors of decline in the NC group. WithinTable 5
Factor loadings for the 6-factor EFA solution—promax rotation
Cognitive test Factor 1 Factor 2 Fac
Stroop Color Naming 0.86 20.11 0
Trails A time 0.86 20.01 20
Trails B time 0.80 20.07 20
Stroop interference 0.73 0.05 0
Stroop Word Reading 0.68 20.03 0
Verbal fluency—FAS 20.39 0.29 20
Verbal fluency—animal 20.40 0.36 0
Digit symbol 20.80 20.02 0
Long delay free recall 0.03 1.02 20
Short delay free recall 20.03 1.00 20
Trails 1–5 total raw score 20.08 0.90 20
ROCF copy 0.09 20.07 0
Block design 20.04 20.05 0
ROCF 3-min delay 20.12 0.25 0
WMS-III visual reproduction II 20.06 0.34 0
WMS-III visual reproduction I 20.30 0.19 0
Boston Naming Test 0.04 0.03 0
WMS-III-logical memory (LM) I 20.08 0.59 0
WMS-III-LM II 20.18 0.51 0
WAIS-III digit span backward 20.04 0.02 0
WAIS-III digit span forward 0.00 20.08 20
Categories 20.29 0.44 0
Variance explained by each factor 68.0% 10.0% 8
Abbreviations: EFA, exploratory factor analysis; ROCF,ReyOsterriethComplexthe MCI group, the memory (P 5 .0003, AUC 5 0.87), ex-
ecutive (P 5 .03, AUC 5 0.77), and attention (P 5 .03,
AUC 5 0.77) domains were significant predictors of
decline to dementia.
The EFA-derived composites produced no significant
predictors of decline for subjects who were normal at base-
line across all three methods. Using the average of the
scores, which loaded highest on each factor, factor 1 (atten-
tion/executive) had the best prediction accuracy of 0.77 for
the NC group, but did not reach statistical significance. For
subjects who were MCI at baseline, factors 1 and 2 (verbal
memory and attention/executive, respectively) were signifi-
cant predictors of decline. Factor 2 (verbal memory) had thetor 3 Factor 4 Factor 5 Factor 6 Factor 7
.21 0.20 20.01 20.02 0.19
.10 20.12 0.20 20.01 20.12
.13 20.14 20.03 0.10 20.21
.12 20.21 0.00 20.09 0.09
.03 0.31 20.15 20.14 20.09
.01 0.08 0.19 0.14 0.10
.02 0.08 0.00 20.07 0.06
.14 0.07 0.08 20.20 20.11
.03 0.09 0.00 20.05 0.04
.06 20.08 0.01 20.08 20.03
.05 0.05 20.02 0.01 0.08
.81 0.08 0.22 20.25 0.09
.73 0.30 20.04 0.10 0.46
.58 0.04 0.02 0.01 20.07
.58 20.07 20.08 0.08 20.05
.42 20.19 20.05 0.10 0.00
.18 0.79 20.03 0.19 0.09
.01 0.46 0.01 0.06 20.14
.02 0.39 0.03 0.03 20.27
.16 20.05 0.78 0.18 20.02
.12 0.36 0.17 0.77 0.02
.27 20.23 0.04 20.04 0.36
.0% 6.0% 4.0% 2.0% 2.0%
Figure;WCST,WisconsinCard SortingTest;WMS,WechslerMemoryScale.
Table 6
AUC for all measures at baseline—univariate models
Methods
NCdecliner MCIdecliner
P value AUC (95% CI) P value AUC (95% CI)
Method 1: theoretical grouping (average)
Memory NS 75% (0.59–0.93) .002 94% (0.87–1.0)
Executive NS 80% (0.66–0.95) .03 75% (0.62–0.88)
Attention NS 75% (0.56–0.93) .002 82% (0.71–0.92)
Language NS 76% (0.57–0.94) .03 76% (0.65–0.88)
Visual spatial NS 73% (0.53–0.93) NS 73% (0.62–0.85)
Method 2: theoretical grouping (minimum)
Memory NS 73% (0.52–0.94) .0003 87% (0.79–0.95)
Executive NS 75% (0.57–0.93) .03 77% (0.66–0.88)
Attention NS 74% (0.55–0.93) .03 77% (0.66–0.88)
Language NS 74% (0.54–0.93) NS 74% (0.62–0.86)
Visual spatial NS 78% (0.61–0.96) NS 73% (0.61–0.85)
Method 3: exploratory factor analysis—varimax rotation (average)
Factor 1 (attention/executive) NS 77% (0.60–0.95) .008 80% (0.67–0.91)
Factor 2 (verbal memory) NS 75% (0.58–0.93) .003 92% (0.83–1.0)
Factor 3 (visuospatial/visual reproduction) NS 74% (0.56–0.93) NS 74% (0.62–0.85)
Method 4: exploratory factor analysis—varimax rotation (factor scores)
Factor 1 (attention/executive) NS 72% (0.54–0.91) .02 83% (0.68–0.97)
Factor 2 (verbal memory) NS 76% (0.56–0.95) NS 80% (0.63–0.96)
Factor 3 (visuospatial/visual reproduction) NS 72% (0.52–0.92) NS 72% (0.53–0.91)
Method 5: exploratory factor analysis—oblique rotation (factor scores)
Factor 1 NS 75% (0.57–0.91) .009 85% (0.73–0.99)
Factor 2 NS 75% (0.56–0.93) .006 89% (0.76–1.00)
Factor 3 NS 74% (0.53–0.94) NS 77% (0.61–0.94)
Factor 4 NS 73% (0.53–0.93) .03 83% (0.68–0.98)
Factor 5 NS 74% (0.54–0.94) NS 73% (0.55–0.93)
Abbreviations: AUC, area under the curve; MCI, mild cognitive impairment; MCIdecliner, MCI subjects who progressed to dementia; NC, cognitively
normal; NCdecliner, NC subjects who progressed to MCI; NS 5 not significant; WAIS-III, Wechsler Adult Intelligence Scale, third edition.
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factor 1 (attention/executive, P5 .008, AUC5 0.80). Using
the factor scores from the varimax rotation, the only
significant predictor of decline in the MCI group was factor
1, which comprised attention/executive (P 5 .02,
AUC5 0.83). Three factors from the EFAwith promax rota-
tion significantly predicted decline to dementia: factor 1 had
a classification accuracy of 85%, factor 2 had a classification
accuracy of 89%, and factor 4 had a classification accuracy
of 83%. Results of the leave-one-out cross validation for the
MCI group are presented in Table 7.
4. Discussion
The goal of our study was to compare the ability of
theoretical and statistically derived cognitive composites
in predicting cognitive decline from NC to MCI and
from MCI to dementia in a longitudinal cohort of well-
characterized subjects. Overall, the composite indices
were better at classifying subjects who were MCI at base-
line than those who were normal. For subjects who were
normal at baseline, classification accuracy was best for
composites that included executive function tests, except
in the case where the factor scores from the varimax rota-
tion were used in which the verbal memory tests produced
the best classification accuracy. However, none of these re-
sults reached statistical significance. Nevertheless, thisobservation is in line with previous findings that decline
in nonmemory domains can be useful in predicting cogni-
tive decline from NC to MCI [34].
Statistically significant classification accuracy was seen
in MCI subjects with both EFA and theoretical composites.
The theoretically derived memory domain (including both
verbal and nonverbal memory) and factor 2 (verbal memory
alone) using the average scores, which loaded highest on
each factor had the best classification accuracy
(AUC 5 0.94 and 0.92, respectively). This observation is
consistent with previous reports [19,31]. Although the EFA
composites did not outperform the theoretically derived
composite, only six cognitive tests were needed in the
EFA-derived memory composite (factor 2) compared with
eight cognitive tests used in the theoretically derived mem-
ory domain which to achieve similar accuracy as visual
reproduction I and II loaded highest on factor 3. Perfor-
mance on the executive and attentionmeasures also achieved
significance in outcome prediction in MCI. These were
considered independent domains in the theoretical compos-
ites but were grouped together by the EFA as has been seen
previously in other studies [32,33,35].
On close examination of the factor loadings of various
tests, several additional interesting observations could be
made. The attention/executive domain included, in addition
to the classic tests tapping into these two functions, two
Table 7
Comparison of the AUC for MCIdecliner models—full data set versus cross
validation
Methods Full data set Cross validation
Method 1: theoretical grouping (average)
Memory 94% (0.87–1.0) 85% (0.74–0.96)
Executive 75% (0.62–0.88) 61% (0.46–0.77)
Attention 82% (0.71–0.92) 71% (0.59–0.84)
Language 76% (0.65–0.88) 66% (0.53–0.79)
Visual spatial 73% (0.62–0.85) 63% (0.49–0.76)
Method 2: theoretical grouping (minimum)
Memory 87% (0.79–0.95) 81% (0.72–0.91)
Executive 77% (0.66–0.88) 67% (0.54–0.79)
Attention 77% (0.66–0.88) 69% (0.56–0.82)
Language 74% (0.62–0.86) 63% (0.50–0.76)
Visual spatial 73% (0.61–0.85) 61% (0.48–0.75)
Method 3: exploratory factor analysis—varimax rotation (average)
Factor 1 (attention/executive) 80% (0.67–0.91) 68% (0.53–0.83)
Factor 2 (verbal memory) 92% (0.83–1.0) 86% (0.74–0.98)
Factor 3 (visuospatial/visual
reproduction)
74% (0.62–0.85) 62% (0.48–0.75)
Method 4: exploratory factor analysis—varimax rotation (factor scores)
Factor 1 (attention/executive) 83% (0.68–0.97) 64% (0.43–0.84)
Factor 2 (verbal memory) 80% (0.63–0.96) 58% (0.36–0.80)
Factor 3 (visuospatial/visual
reproduction)
72% (0.53–0.91) 44% (0.23–0.66)
Method 5: exploratory factor analysis—oblique rotation (factor scores)
Factor 1 85% (0.73–0.99) 70% (0.52–0.88)
Factor 2 89% (0.76–1.00) 77% (0.59–0.96)
Factor 3 77% (0.61–0.94) 56% (0.36–0.76)
Factor 4 83% (0.68–0.98) 64% (0.44–0.85)
Factor 5 73% (0.55–0.93) 44% (0.24–0.65)
Abbreviations: AUC, area under the curve; MCI, mild cognitive impair-
ment; MCIdecliner, MCI subjects who progressed to dementia.
H. Wilhalme et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 6 (2017) 171-181 179tests that are traditionally grouped in the language domain
(animal and phonemic fluency). This is most likely because
both of these tests have a significant executive component.
To successfully perform these two tasks, the subject must
understand and keep in mind the instructions he or she
was given and conduct an efficient search of the mental
lexicon, all the while suppressing irrelevant responses
and repetition [52]. Two executive strategies commonly
used to facilitate speedy retrieval of relevant items on these
tasks are clustering and switching. Clustering relies on sys-
tematic exploration of subcategories (e.g., farm animals) or
in the case of letter fluency tasks, by orthographic similar-
ity [53]. Switching refers to the conscious shift to another
subcategory (e.g., from farm animals to forest animals,
then to aquatic animals, and so forth). Thus, performance
of these tasks is dependent on both verbal ability and exec-
utive function and, of these two cognitive domains, execu-
tive abilities are affected earlier in the disease course.
It is also worth noting that EFA-derived factors 1 to 3
(varimax rotation) explained 84% of the variance between
the groups with the attention/executive factor alone explain-
ing 66% of the variance. Several studies have over the years
reported the significant role executive function plays in MCI
progression [14,33,34,54,55]. Using the ADNI cohort,Gibbons et al. [14] previously demonstrated that the execu-
tive domain is a powerful predictor of conversion from MCI
to AD. Another Alzheimer’s Disease Neuroimaging (ADNI)
study reported that subjects with amnestic MCI show faster
decline in executive function compared with memory [34].
There are a variety of approaches to factor analysis based
on assumptions made about a particular data set. Although
using an orthogonal rotation produces more easily interpret-
able results, in our data we would expect some correlation
between the results of the NP tests, whether they are consid-
ered memory, executive function, attention, language, or vi-
suospatial. Therefore, using an oblique rotation may be more
appropriate. In our data set, we found that the factor scores
produced from the promax rotation indeed outperformed
those from the varimax rotation. Three factors—factor 1,
factor 2, and factor 4—significantly predicted decline to de-
mentia with AUCs of 85%, 89%, and 83% respectively,
whereas only factor 1 from the varimax rotation significantly
predicted decline (AUC 5 0.83). Although these results are
good evidence for using the oblique rotation, both methods
using the factor scores did not perform as well as the com-
posites calculated from averaging, which is a more straight-
forward procedure.
There are some limitations to this study that should be
considered. Our subjects were predominantly Caucasian
and highly educated. Several cross-sectional studies
have shown that there are significant differences in
cognitive performance across races [56–59]. These
studies found higher rates of cognitive impairment,
dementia, and AD among minorities compared with
Whites. Some studies have also shown that the racial
differences also extend to cognitive decline over time.
Looking at telephone interview for cognitive status
scores for more than 3 years of 113 MCI subjects from
the Memory and Medical Care Study, Lee et al. (2012)
found that the rate of cognitive decline appears to be
faster in African Americans than non–African Americans
in the community [60]. Another study, however, showed
that the rate of cognitive decline in 452 clinically diag-
nosed AD patients appears to be slower in African Amer-
icans than non–African Americans [61]. Taken together,
these studies suggest that cognitive ability varies across
races. As such, our findings may not generalize well to
the broad community. Another limitation, which is likely
responsible for the lack of significance in the predictive
model in NC, is the relatively small sample size of the
NC group, especially the NCdecliner group.
In conclusion, none of the EFA-derived or theoretical
domains were able to predict decline in NC with sufficient
accuracy. Equally excellent predictive accuracy of future
decline was seen with both the EFA and the theoretical
memory composites in MCI; however, the EFA solution
achieved this accuracy using fewer cognitive tests relative
to the theoretical approach. Therefore, in research settings
in which a briefer battery is desirable, the EFA approach
might be preferable. In addition to memory, the executive
H. Wilhalme et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 6 (2017) 171-181180function composite also achieved significance in predicting
cognitive decline in MCI.
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1. Systematic review: Both theoretical and data-driven
composite scores have been used in research set-
tings for predicting cognitive decline. Our literature
review included extensive PubMed database search
for original research examining the performance of
theoretical and data-driven approaches in diagnosing
cognitive impairment and predicting future cognitive
decline associated with Alzheimer’s disease.
2. Interpretation: Our objective was to compare the ac-
curacy of theoretically and statistically derived neu-
ropsychological composites for predicting cognitive
decline. Both the theoretical and the exploratory fac-
tor analyses resulted in composite measures in the
memory and executive domains that achieved high
accuracy in predicting progression from mild cogni-
tive impairment to dementia. Neither method was
sensitive enough to predict future cognitive decline
in cognitively normal individuals.
3. Future directions: Future studies including new
cognitive measures highly sensitive to subtle cogni-
tive decline might be needed to identify cognitively
normal individuals in the asymptomatic stages of
Alzheimer’s disease.
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